Aims To assess cytokine levels in peripheral blood and tears of patients after allogeneic haematopoietic stem cell ...
Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today reiterated that its allogeneic cell therapy products are manufactured from U.S ...
CancerBuddy connects users through shared diagnoses and experiences, offering community when hospital walls feel especially ...
When Sherry received a diagnosis of endometrial cancer, her life was forever changed. Learn more about her journey.
Imminent launch of grant-funded clinical trial in graft-versus-host disease (GVHD)Advancing clinical program in severe pulmonary inflammatory ...
This article explores how stem cell therapies and organoid models are advancing Alzheimer’s research. It highlights progress ...
KSNW Wichita on MSN
Kansas medical devices removed over ‘dirty bomb’ fears
The U.S. Department of Energy's National Nuclear Security Administration has removed Cesium-137 Irradiators from medical ...
Damien Thompson is no stranger to hospital beds, having spent the last 15 years receiving treatment on and off after he was ...
Jack Ricketts sadly left behind a devastated fiancé and three-year-old daughter as he was placed into a coma and died last ...
Positive results from Phase 3 trial for MaaT013 in acute Graft-versus-Host disease (aGvHD); topline results showed a 62% gastrointestinal overall response rate at Day 28 and 1-year expected Overall ...
Following recent constructive FDA feedback, Seres anticipates finalizing SER-155 Phase 2 study protocol for the prevention of bloodstream ...
UC Davis Health gastroenterology researchers have received a $2.8 million grant (R01EB037526) from the National Institute of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results